These final results, together with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 assist the notion of focusing on ACKR3 as a novel solution to modulate the opioid process, which could open new therapeutic avenues for opioid-relevant Problems. Take note: Benefits may https://sparkyu135mfb4.sharebyblog.com/profile